Colon cancer is a big deal in both China and the United States. But how do these two countries compare when it comes to who gets it, where it hits, and how well people survive? Let's dive in.

Over a decade, from 2006 to 2019, the US saw more new cases of colon cancer than China. In China, the cancer often struck guys more than gals (58. 9% vs 41. 1%), and it tended to hit people a bit earlier, at a median age of 64. In the US, it was more evenly split between genders, and people were typically diagnosed at 66 years old.

Where does this cancer usually grow? In China, it was often found in the rectosigmoid colon (66. 5%), then the rectum (20. 2%), and least in the left colon area (13. 3%). In the US, it was more common in the rectum (44. 4%), followed by the rectosigmoid colon (29. 8%), and then the left colon area (25. 8%).

Surgery is a common treatment. In China, fewer patients with cancer in the rectum (92. 3% vs 93. 9%) and left colon (88. 9% vs 92. 0%) got the radical surgery needed. Plus, fewer Chinese patients overall got extra therapy after surgery to kill any remaining cancer cells.

Survival rates matter. In the US, 78. 2% of patients lived for at least five years after diagnosis. In China, that rate was lower, at 71. 8%.

China is seeing more colon cancer cases, and how it's treated and survived differs from the US. So, what can China learn from the US, and vice versa?

Colorectal Cancer: A Tale of Two Nations

Actions